Louisiana House Votes to Expand Right to Try Act, Further Reject Some FDA Restrictions

BATON ROUGE, La. (May 18, 2017) – Yesterday, the Louisiana House unanimously passed a bill that would expand the state’s Right to Try law to include technology designed to help ALS patients with mobility. Passage into law would set the foundation to nullify in practice a Food and Drug Administration (FDA) rule that currently denies these patients’ access to this specific technology.

Details

Louisiana Committee Passes Bill to Expand Right to Try Act, Further Reject Some FDA Restrictions

BATON ROUGE, La. (May 11, 2017) – On Wednesday, a Louisiana House committee unanimously passed a bill that would expand the state’s Right to Try law to include technology designed to help ALS patients with mobility. Passage into law would set the foundation to nullify in practice a Food and Drug Administration (FDA) rules that currently denies these patients’ access to this specific technology.

Details

Texas House Votes to Expand Right to Try Act; Further Reject Some FDA Restrictions on Personal Choice

AUSTIN, Texas (May 14, 2017) – On Friday, the Texas House unanimously passed a bill that would expand the Texas “Right to Try” law, setting the foundation to nullify in practice additional Food and Drug Administration (FDA) rules that deny access to experimental treatments by patients with severe chronic diseases.

Details

Louisiana Bill Would Expand Right to Try Act, Further Rejecting Some FDA Restrictions

BATON ROUGE, La. (May 9, 2017) – A bill introduced in the Louisiana House would expand the states Right to Try law to include technology designed to help ALS patients with mobility. Passage into law would set the foundation to nullify in practice a Food and Drug Administration (FDA) rules that deny these patients’ access to this specific technology.

Details

Texas Committee Votes to Expand Right to Try Act; Further Reject Some FDA Restrictions on Personal Choice

AUSTIN, Texas (May 1, 2017) – Last week, a Texas House committee unanimously passed a bit that would expand the Texas “Right to Try” law, setting the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by patients with severe chronic diseases.

Details